Fas-independent mitochondrial damage triggers cardiomyocyte death after ischemia-reperfusion

Area of Science:

• Cardiovascular Biology
• Cell Death Mechanisms
• Mitochondrial Physiology

Background:

• The Fas/Fas ligand and mitochondrial pathways contribute to cell death in various cell types.
• Ischemia-reperfusion (I/R) injury is a critical factor in cardiovascular disease, leading to significant cardiomyocyte death.
• Understanding the dominant pathway in I/R-induced cell death is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate whether the Fas pathway or mitochondrial pathways are predominantly activated during prolonged ischemia-reperfusion (I/R) injury in the heart.
• To determine the role of the mitochondrial permeability transition pore (mPTP) in I/R-induced cardiomyocyte death.

Main Methods:

• Genetic inactivation of the Fas receptor (lpr mice) and pharmacological inhibition of mPTP using cyclosporin A (CsA).
• Induction of 25 minutes of ischemia followed by 24 hours of reperfusion in C57BL/6JICO (control) and C57BL/6-lpr mice.
• Assessment of infarct size, myocardial apoptosis (caspase 3 activity), and mPTP opening (Ca2+-induced opening).

Main Results:

• Infarct size was comparable between control and lpr mice, but significantly reduced by CsA treatment in both groups.
• Caspase 3 activity, an indicator of apoptosis, increased similarly in control and lpr hearts and was significantly reduced by CsA.
• CsA treatment attenuated Ca2+-induced mPTP opening in both control and lpr mice, indicating preserved mitochondrial function.

Conclusions:

• The Fas pathway plays a minor role in cardiomyocyte death following lethal ischemia-reperfusion injury.
• Mitochondria, specifically through the mitochondrial permeability transition pore (mPTP), are preferentially involved in I/R-induced heart cell death.
• Pharmacological inhibition of mPTP offers a potential therapeutic strategy to mitigate I/R injury.